Clinical Trials · NCT00274170

Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache

UnknownPhase 1/Phase 2Octreotide (Unclear)
Phase
Phase 1/Phase 2
Recruitment status
Unknown
Sponsor
C.R.Darnall Army Medical Center
Enrollment
56
Start date
Jan 2006
Locations
1 site, United States
Primary endpoint
Patient Satisfaction
View Octreotide compound reference